Presentation is loading. Please wait.

Presentation is loading. Please wait.

Distribution of immune checkpoint in tumor cells and immune microenvironment. CTLA-4, cytotoxic T lymphocyte antigen-4; MHC, major histocompatibility complex;

Published byAbigail Strickland Modified over 5 years ago

Similar presentations

Presentation on theme: "Distribution of immune checkpoint in tumor cells and immune microenvironment. CTLA-4, cytotoxic T lymphocyte antigen-4; MHC, major histocompatibility complex;"— Presentation transcript:

1 Distribution of immune checkpoint in tumor cells and immune microenvironment. CTLA-4, cytotoxic T lymphocyte antigen-4; MHC, major histocompatibility complex; PD-1/PD-2, programmed cell death-1/-2; PD-LI/PD-L2, programmed cell death receptor-1/-2 ligand; TCR, T cell receptor. Distribution of immune checkpoint in tumor cells and immune microenvironment. CTLA-4, cytotoxic T lymphocyte antigen-4; MHC, major histocompatibility complex; PD-1/PD-2, programmed cell death-1/-2; PD-LI/PD-L2, programmed cell death receptor-1/-2 ligand; TCR, T cell receptor. Tanvir F. Kabir et al. TOJ 2018;18: Copyright © 2018 by Ochsner Clinic Foundation

Download ppt "Distribution of immune checkpoint in tumor cells and immune microenvironment. CTLA-4, cytotoxic T lymphocyte antigen-4; MHC, major histocompatibility complex;"

Similar presentations

Targeting Immune Checkpoints in Esophageal Cancer: A High Mutational Load Tumor  Rajeev Dhupar, MD, Lauren Van Der Kraak, PhD, Arjun Pennathur, MD, Matthew.

Targeting Immune Checkpoints in Esophageal Cancer: A High Mutational Load Tumor  Rajeev Dhupar, MD, Lauren Van Der Kraak, PhD, Arjun Pennathur, MD, Matthew.
David P. Carbone, MD, PhD, David R. Gandara, MD, Scott J

David P. Carbone, MD, PhD, David R. Gandara, MD, Scott J
Intracellular Pathogens Extracellular Pathogens

Intracellular Pathogens Extracellular Pathogens
Figure 1 CTLA-4 and PD-1–PD-L1 immune checkpoints

Figure 1 CTLA-4 and PD-1–PD-L1 immune checkpoints
Adverse Renal Effects of Immune Checkpoint Inhibitors:

Adverse Renal Effects of Immune Checkpoint Inhibitors:
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers  Ivana Catacchio, Anna Scattone, Nicola.

Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers  Ivana Catacchio, Anna Scattone, Nicola.
Figure 1 Immunomodulatory monoclonal antibodies and armoured chimeric antigen receptor (CAR) T cells overcome immune suppression Figure 1 | Immunomodulatory.

Figure 1 Immunomodulatory monoclonal antibodies and armoured chimeric antigen receptor (CAR) T cells overcome immune suppression Figure 1 | Immunomodulatory.
Figure 3 Altered adaptive immune functions after sepsis

Figure 3 Altered adaptive immune functions after sepsis
Figure 2 Neoantigen presentation in the tumour microenvironment

Figure 2 Neoantigen presentation in the tumour microenvironment
Volume 199, Issue 5, Pages (May 2018)

Volume 199, Issue 5, Pages (May 2018)
Heating is a multifunctional adjuvant that affects tumor microenvironment through several intrinsic and extrinsic mechanisms, which could enhance immunotherapy.

Heating is a multifunctional adjuvant that affects tumor microenvironment through several intrinsic and extrinsic mechanisms, which could enhance immunotherapy.
Antibody-modified T cells: CARs take the front seat for hematologic malignancies by Marcela V. Maus, Stephan A. Grupp, David L. Porter, and Carl H. June.

Antibody-modified T cells: CARs take the front seat for hematologic malignancies by Marcela V. Maus, Stephan A. Grupp, David L. Porter, and Carl H. June.
Figure 7 Clinical options for HCC therapy

Figure 7 Clinical options for HCC therapy
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New  Anagha Bangalore Kumar, MBBS, Rachel Maus, PhD,

Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New  Anagha Bangalore Kumar, MBBS, Rachel Maus, PhD,
Latest Advances in Chemotherapeutic, Targeted, and Immune Approaches in the Treatment of Metastatic Melanoma  Darshil J. Shah, MD, MPH, Roxana S. Dronca,

Latest Advances in Chemotherapeutic, Targeted, and Immune Approaches in the Treatment of Metastatic Melanoma  Darshil J. Shah, MD, MPH, Roxana S. Dronca,
Schematic diagram outlining the antitumor activity and abscopal effect in combining checkpoint inhibitors with radiation-induced immune response. Schematic.

Schematic diagram outlining the antitumor activity and abscopal effect in combining checkpoint inhibitors with radiation-induced immune response. Schematic.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Similar presentations

Ads by Google